Trials / Completed
CompletedNCT00825396
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
A Pilot, Open-Label, Controlled Clinical Trial of C-KAD Ophthalmic Solution in Reducing Intraocular Pressure in Patients With Ocular Hypertension
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Chakshu Research, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | C-KAD Ophthalmic Solution | 4 drops applied daily for 150 days |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2009-01-21
- Last updated
- 2009-06-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00825396. Inclusion in this directory is not an endorsement.